Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Executive Chair

SVP, Technical Operations

See Remarks

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-18	Premium	acquired	Premium	Premium	Premium	Executive Chair
2023-11-10	Premium	bought	Premium	Premium	Premium	Executive Chair
2023-05-31	Premium	bought	Premium	Premium	Premium	-
2023-05-31	Premium	bought	Premium	Premium	Premium	-
2023-05-31	Premium	bought	Premium	Premium	Premium	-
2023-01-31	Premium	acquired	Premium	Premium	Premium	SVP, Technical Operations
2023-01-31	Premium	acquired	Premium	Premium	Premium	See Remarks
2022-06-10	Premium	bought	Premium	Premium	Premium	-
2022-05-16	Premium	bought	Premium	Premium	Premium	-
2022-05-13	Premium	bought	Premium	Premium	Premium	-
2022-04-12	Premium	bought	Premium	Premium	Premium	-
2022-04-12	Premium	bought	Premium	Premium	Premium	Executive Chair
2022-04-12	Premium	bought	Premium	Premium	Premium	-
2022-04-12	Premium	bought	Premium	Premium	Premium	-
2022-04-12	Premium	bought	Premium	Premium	Premium	-
2021-06-17	Premium	bought	Premium	Premium	Premium	-
2020-12-16	Premium	bought	Premium	Premium	Premium	-
2020-05-05	Premium	bought	Premium	Premium	Premium	-
2020-05-05	Premium	bought	Premium	Premium	Premium	-
2020-05-05	Premium	sold	Premium	Premium	Premium	-
2020-05-05	Premium	acquired	Premium	Premium	Premium	-
2020-05-05	Premium	acquired	Premium	Premium	Premium	-
2020-05-05	Premium	acquired	Premium	Premium	Premium	-
2020-05-05	Premium	sold	Premium	Premium	Premium	-
2020-05-05	Premium	bought	Premium	Premium	Premium	-

LYRA - Lyra Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for LYRA